Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gallbladder Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 13Cisplatin 10Capecitabine 7pembrolizumab 3Oxaliplatin 3Leucovorin 3Chemotherapy, Adjuvant 3durvalumab 2Watchful Waiting 2Fluorouracil 2Dihematoporphyrin Ether 2zanidatamab 1becatecarin 1Tegafur 1Taxes 1Somatostatin 1S 1 (combination) 1Platinum 1Phototherapy 1Photochemotherapy 1Ondansetron 1Neoadjuvant Therapy 1Laser Therapy 1Irinotecan 1Folfox protocol 1Fentanyl 1Escitalopram 1Epirubicin 1Dexamethasone 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gallbladder Neoplasms × becatecarin × Clear all
NCT00090025 2009-01-14

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Helsinn Healthcare SA

Phase 3 Terminated
248 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡